StockData
Roivant Sciences Ltd. logo

Roivant Sciences Ltd. (ROIV) stock

ROIVNasdaqPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$38.71+0.10 (+0.26%)

Close on Nov 17, 2026Market cap $27.96BP/E –Yield –

Roivant Sciences cash

Cash and short-term investments held at the end of each period.

Roivant Sciences's cash was $3.84B at Jun 30, 2026. For fiscal 2025 it was $4.29B, down 12.2% from the year before. The highest annual figure on record is $6.49B in fiscal 2023.

Annual cash

PeriodPeriod endValueChange
FY2025Mar 31, 2026$4.29B-12.2%
FY2024Mar 31, 2025$4.89B-24.8%
FY2023Mar 31, 2024$6.49B+283.8%
FY2022Mar 31, 2023$1.69B-18.4%
FY2021Mar 31, 2022$2.07B-3.2%
FY2020Mar 31, 2021$2.14B-5.6%
FY2019Mar 31, 2020$2.27B–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2026CQ2 2026Jun 30, 2026$3.84B-14.7%
Q4 FY2025CQ1 2026Mar 31, 2026$4.29B-12.2%
Q3 FY2025CQ4 2025Dec 31, 2025$4.53B-12.0%
Q2 FY2025CQ3 2025Sep 30, 2025$4.39B-18.6%
Q1 FY2025CQ2 2025Jun 30, 2025$4.50B-20.7%
Q4 FY2024CQ1 2025Mar 31, 2025$4.89B-24.8%
Q3 FY2024CQ4 2024Dec 31, 2024$5.15B-22.9%
Q2 FY2024CQ3 2024Sep 30, 2024$5.39B+282.5%
Q1 FY2024CQ2 2024Jun 30, 2024$5.68B+291.7%
Q4 FY2023CQ1 2024Mar 31, 2024$6.49B+283.8%
Q3 FY2023CQ4 2023Dec 31, 2023$6.67B+332.9%
Q2 FY2023CQ3 2023Sep 30, 2023$1.41B-12.7%
Q1 FY2023CQ2 2023Jun 30, 2023$1.45B-25.9%
Q4 FY2022CQ1 2023Mar 31, 2023$1.69B-18.4%
Q3 FY2022CQ4 2022Dec 31, 2022$1.54B-30.8%
Q2 FY2022CQ3 2022Sep 30, 2022$1.61B-35.7%
Q1 FY2022CQ2 2022Jun 30, 2022$1.96B-2.6%
Q4 FY2021CQ1 2022Mar 31, 2022$2.07B-3.2%
Q3 FY2021CQ4 2021Dec 31, 2021$2.23B+3.4%
Q2 FY2021CQ3 2021Sep 30, 2021$2.51B+5.0%
Q1 FY2021CQ2 2021Jun 30, 2021$2.01B-13.2%
Q4 FY2020CQ1 2021Mar 31, 2021$2.14B-5.6%
Q3 FY2020CQ4 2020Dec 31, 2020$2.15B–
Q2 FY2020CQ3 2020Sep 30, 2020$2.39B–
Q1 FY2020CQ2 2020Jun 30, 2020$2.31B–
Q4 FY2019CQ1 2020Mar 31, 2020$2.27B–

More Roivant Sciences figures

See a number that looks wrong?